In a patient with an immunobullous disorder, is transportation of the skin biopsy in normal saline adequate for direct immunofluorescence analysis? A critically appraised topic

2013 ◽  
Vol 169 (1) ◽  
pp. 6-10 ◽  
Author(s):  
A.N. Patel ◽  
R.C. Simpson ◽  
S.N. Cohen
2020 ◽  
Vol 2 ◽  
pp. 40-42
Author(s):  
Soumya Jagadeesan ◽  
Malini Eapen ◽  
Aditi Karunakaran ◽  
Vinitha Panicker ◽  
Gopikrishnan Anjaneyan ◽  
...  

A 49-year-old male presented with erythroderma of 3-month duration with a flexural onset. No mucosal lesions were present, and skin biopsy showed features of acantholysis and suprabasal clefting. Direct immunofluorescence test was negative in repeated examinations. The patient was presumptively managed as pemphigus foliaceus with immunomodulators though the level of split was suprabasal rather than subcorneal, and the patient responded well to the treatment. However, his elder sister presented to the department with clinical and histopathological features of classical Hailey–Hailey disease (HHD) which resembled the pathological features found in the index case. This prompted us to review the diagnosis and retrospectively diagnose the index case as HHD presenting with erythroderma.


2020 ◽  
pp. 1-3
Author(s):  
Singh Deeksha ◽  
Agarwal Shilpi ◽  
Chander Ram ◽  
Agarwal Kiran ◽  
Singh Preksha

Vasculitides is a group of disorders characterized by inflammation of vessel wall. Because of its rich vasculature, the skin manifestations are frequently seen in vasculitis. Vasculitis is a clinico-pathologic diagnosis. Histopathologic study of skin biopsy is confirmatory while direct immuofluorescence (DIF) examination is adjunctive to this and helps to categorize the vasculitis. Although the percentages of cases of Cutaneous Vasculitis diagnosed on histopathology & direct immunofluorescence separately were found to be comparable in this study, both techniques have their own place in the confirmation & classification of cutaneous vasculitis particularly in HSP with appropriate clinical correlation.


2010 ◽  
Vol 76 (2) ◽  
pp. 150 ◽  
Author(s):  
Seema Chhabra ◽  
S Singh ◽  
BD Radotra ◽  
Bhushan Kumar ◽  
RanjanaWalker Minz

2017 ◽  
Vol 76 (4) ◽  
pp. 761-763 ◽  
Author(s):  
Raghavendra Rao ◽  
Anuradha Jindal ◽  
Balbir Bhogal ◽  
Sathish B. Pai

Author(s):  
Feng-Zeng Li ◽  
Meng Jia ◽  
Ke-Jun Chen ◽  
Qian Ye ◽  
Sheng Fang

Bullous scabies (BS) is a rare atypical clinical variant of scabies and is easily confused with bullous disorders. The diagnosis of BS is always a challenge, and physicians often misdiagnose BS patients. Patients with BS admitted from 2012 to 2020 were enrolled in this study. The clinical, dermoscopic, and pathological characteristics of the patients were analyzed retrospectively. Ten patients with BS were enrolled in this study. Seven of the 10 patients were male. The bullae were most commonly found on the thighs and arms (80% of patients). Only 30% of patients (3/10) tested positive for mites and/or eggs by the initial skin scraping, but 100% (5/5) of the patients who received dermoscopy tested positive. Among these 10 patients, only five received a skin biopsy. Subepidermal (4/5) and intraepidermal (1/5) bullae with eosinophil and neutrophil infiltration were observed in five patients. Direct immunofluorescence (DIF) indicated linear deposition of IgG in the basement membrane zone in three patients. Physicians should consider the possibility of BS in patients with blisters, pruritus, and poor response to corticosteroids. Dermoscopy should be prioritized for the differential diagnosis of BS to exclude other bullous disorders. Finally, a biopsy should be performed on each patient with bullae.


2014 ◽  
Vol 18 (6) ◽  
pp. 392-396 ◽  
Author(s):  
Chris Sladden ◽  
Mark G. Kirchhof ◽  
Richard I. Crawford

Background: Bullous pemphigoid (BP) is an autoimmune polymorphic skin disease characterized by erythematous papules and plaques and tense bullae. A skin biopsy for direct immunofluorescence (DIF) is used to detect autoantibodies and complement proteins. Objective: We sought to determine which location would provide the highest probability of obtaining a positive DIF result. Method: We undertook a retrospective chart review of 1,423 DIF biopsies. Biopsies with a clinical suspicion of BP were designated as either lesional, perilesional, or indeterminate. Results: Fifty percent of lesional DIF biopsies were positive, whereas 22% of perilesional and 12% of indeterminate biopsies had a positive DIF result. The odds ratio of a positive DIF from a lesional versus perilesional biopsy site was found to be 3.45 (95% CI 1.44–8.29). Conclusion: Clinicians are more likely to obtain a positive DIF result from a lesional nonbullous skin biopsy than from a perilesional or normal skin biopsy.


Sign in / Sign up

Export Citation Format

Share Document